<?xml version='1.0' encoding='UTF-8' ?>
<rss version='2.0' xmlns:itunes='http://www.itunes.com/dtds/podcast-1.0.dtd' xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<atom:link href="http://www.vemcomeded.com/mrsa/VMEPodcast_3123_20100930.xml" rel="self" type="application/rss+xml" />
	<language>en-us</language>
	<itunes:owner>
		<itunes:name>Vemco MedEd LLC</itunes:name>
		<itunes:email>info@vemcomeded.com</itunes:email>
	</itunes:owner>
	<itunes:explicit>No</itunes:explicit>
	<itunes:category text="Education" />
	<itunes:image href="http://www.vemcomeded.com/liveregistration/V3123-MRSA-FAQs.jpg" />
	<title>Let's Talk MRSA: 20 Frequently Asked Questions </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<itunes:subtitle>
Designed to clarify persistent issues in serious MRSA infections that pose 
a threat to patient safety and add to the healthcare burden. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.
	</itunes:subtitle>
	<itunes:summary>
Designed to clarify persistent issues in serious MRSA infections that pose 
a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.
	</itunes:summary>
	<description>
Designed to clarify persistent issues in serious MRSA infections that pose 
a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.
	</description>
	<link>http://www.vemcomeded.com/ </link>
	<image>
		<link>http://www.vemcomeded.com/ </link>
		<title>Let's Talk MRSA: 20 Frequently Asked Questions </title>
		<url>http://www.vemcomeded.com/liveregistration/v3123-MRSA-FAQs.jpg</url>
		<width>97</width>
		<height>97</height>
	</image>
<item>
	<title>What are the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. George G. Zhanel from University of Manitoba, Winnipeg, Canada provides insights 
on the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections.
	</description>
	<pubDate>Sun, 13 Feb 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM4E5.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM4E5.mov </guid>
	<itunes:subtitle>In this Episode, Dr. George G. Zhanel from University of Manitoba, Winnipeg, Canada provides insights on the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. George G. Zhanel from University of Manitoba, Winnipeg, Canada provides insights on the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM4E5.mov'  length='5696563' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>How can we prevent the spread of MRSA in the hospital? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas 
provides insights on how we can prevent the spread of MRSA in the hospital. 
	</description>
	<pubDate>Sun, 6 Feb 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM4E4.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM4E4.mov </guid>
	<itunes:subtitle>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on how we can prevent the spread of MRSA in the hospital. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on how we can prevent the spread of MRSA in the hospital. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM4E4.mov'  length='6771225' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Is there a role for OPAT in the management of patients with MRSA infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas 
provides insights on the role for OPAT in the management of patients with MRSA infections. 
	</description>
	<pubDate>Sun, 30 Jan 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM4E3.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM4E3.mov </guid>
	<itunes:subtitle>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on the role for OPAT in the management of patients with MRSA infections. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on the role for OPAT in the management of patients with MRSA infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM4E3.mov'  length='6349843' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Can we determine the appropriate duration of therapy for MRSA infections?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, 
Texas provides insights on appropriate duration of therapy for MRSA infections.
	</description>
	<pubDate>Sun, 23 Jan 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM4E2.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM4E2.mov </guid>
	<itunes:subtitle>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on appropriate duration of therapy for MRSA infections.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on appropriate duration of therapy for MRSA infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM4E2.mov'  length='8286983' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What stewardship tactics can be applied to the management of MRSA infections?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas 
provides insights on stewardship tactics that can be applied to the management of MRSA infections. 
	</description>
	<pubDate>Sun, 16 Jan 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM4E1.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM4E1.mov </guid>
	<itunes:subtitle>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on stewardship tactics that can be applied to the management of MRSA infections. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center, San Antonio, Texas provides insights on stewardship tactics that can be applied to the management of MRSA infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM4E1.mov'  length='8145340' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Can we differentiate among newer agents for MRSA bacteremia and endocarditis?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center in San Antonio, 
Texas provides insights on differentiation among newer agents for MRSA bacteremia and endocarditis.
	</description>
	<pubDate>Sun, 9 Jan 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E7.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E7.mov </guid>
	<itunes:subtitle>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center in San Antonio, Texas provides insights on differentiation among newer agents for MRSA bacteremia and endocarditis.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center in San Antonio, Texas provides insights on differentiation among newer agents for MRSA bacteremia and endocarditis.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E7.mov'  length='8448600' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>How should clinicians manage MRSA bacteremia and infective endocarditis?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
Description: In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of 
Medicine in Rootstown, Ohio provides insights on how clinicians should manage MRSA bacteremia and infective endocarditis.
	</description>
	<pubDate>Sun, 2 Jan 2011 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E6.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E6.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on how clinicians should manage MRSA bacteremia and infective endocarditis.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on how clinicians should manage MRSA bacteremia and infective endocarditis.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E6.mov'  length='5804343' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>How can primary care physicians manage community-associated MRSA pneumonia?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in 
Rootstown, Ohio provides insights on how primary care physicians can manage community-associated MRSA pneumonia.
	</description>
	<pubDate>Sun, 26 Dec 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E5.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E5.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on how primary care physicians can manage community-associated MRSA pneumonia.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on how primary care physicians can manage community-associated MRSA pneumonia.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E5.mov'  length='5487624' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What is the optimal treatment for MRSA nosocomial pneumonia? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in 
Rootstown, Ohio provides insights on optimal treatment for MRSA nosocomial pneumonia. 
	</description>
	<pubDate>Sun, 19 Dec 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E4.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E4.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on optimal treatment for MRSA nosocomial pneumonia.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on optimal treatment for MRSA nosocomial pneumonia.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E4.mov'  length='6644915' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What are the therapeutic options for a complicated skin or skin structure MRSA infection? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in 
Rootstown, Ohio provides insights on therapeutic options for a complicated skin or skin structure MRSA infection. 
	</description>
	<pubDate>Sun, 12 Dec 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E3.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E3.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on therapeutic options for a complicated skin or skin structure MRSA infection.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on therapeutic options for a complicated skin or skin structure MRSA infection. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E3.mov'  length='7708867' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>How can clinicians optimally manage community-associated MRSA skin infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in 
Rootstown, Ohio provides insights on optimal management of community-associated MRSA skin infections. 
	</description>
	<pubDate>Sun, 05 Dec 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E2.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E2.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on optimal management of community-associated MRSA skin infections.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on optimal management of community-associated MRSA skin infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E2.mov'  length='6836199' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What strategies can be used to effectively manage patients with skin and soft tissue MRSA infections?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio 
provides insights on strategies to effectively manage patients with skin and soft tissue MRSA infections. 
	</description>
	<pubDate>Sun, 28 Nov 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM3E1.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM3E1.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on strategies to effectively manage patients with skin and soft tissue MRSA infections. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on strategies to effectively manage patients with skin and soft tissue MRSA infections. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM3E1.mov'  length='10034934' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>When should an alternative agent to vancomycin be considered for MRSA infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights 
on when an alternative agent to vancomycin should be considered for MRSA infections.
	</description>
	<pubDate>Sun, 21 Nov 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM2E4.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM2E4.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM2E4.mov'  length='7691451' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What are the toxicity concerns associated with using vancomycin for MRSA infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights 
on toxicity concerns associated with vancomycin use.
	</description>
	<pubDate>Sun, 14 Nov 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM2E3.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM2E3.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on toxicity concerns associated with vancomycin use.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on toxicity concerns associated with vancomycin use.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM2E3.mov'  length='8512100' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Should therapeutic drug monitoring be considered when using vancomycin for MRSA infections? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights 
on vancomycin therapeutic drug monitoring.
	</description>
	<pubDate>Sun, 7 Nov 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM2E2.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM2E2.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on vancomycin therapeutic drug monitoring.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on vancomycin therapeutic drug monitoring.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM2E2.mov'  length='7213764' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What is the appropriate vancomycin dosing to maximize its effectiveness?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights 
on appropriate vancomycin dosing to maximize effectiveness.
	</description>
	<pubDate>Sun, 31 Oct 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM2E1.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM2E1.mov </guid>
	<itunes:subtitle>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on appropriate vancomycin dosing to maximize effectiveness.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on appropriate vancomycin dosing to maximize effectiveness.</itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM2E1.mov'  length='4949645' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What is vancomycin 'MIC creep'? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights
 on vancomycin 'MIC creep', the evidence and its implications. 
	</description>
	<pubDate>Sun, 24 Oct 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM1E4.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM1E4.mov </guid>
	<itunes:subtitle>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on vancomycin 'MIC creep', the evidence and its implications.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on vancomycin 'MIC creep', the evidence and its implications. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM1E4.mov'  length='8989896' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>What is community-associated MRSA? How is it different from healthcare-acquired MRSA? </title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights 
on community-associated MRSA and healthcare-acquired MRSA. 
	</description>
	<pubDate>Sun, 17 Oct 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM1E3.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM1E3.mov </guid>
	<itunes:subtitle>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on community-associated MRSA and healthcare-acquired MRSA. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on community-associated MRSA and healthcare-acquired MRSA. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM1E3.mov'  length='8225385' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Why is the prevalence of MRSA increasing in the hospital setting?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights 
on why the prevalence of MRSA is increasing in the hospital setting.  
	</description>
	<pubDate>Sun, 10 Oct 2010 10:02:22 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM1E2.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM1E2.mov </guid>
	<itunes:subtitle>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why the prevalence of MRSA is increasing in the hospital setting. </itunes:subtitle>
	<itunes:summary>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why the prevalence of MRSA is increasing in the hospital setting. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM1E2.mov'  length='7100519' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
<item>
	<title>Why is MRSA such a problematic pathogen?</title>
	<itunes:author>Vemco MedEd</itunes:author>
	<description>
In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights 
on why MRSA is such a problematic pathogen. 
	</description>
	<pubDate>Wed, 29 Sep 2010 10:05:25 EST</pubDate>
	<link>http://www.vemcomeded.com/mrsa/LM1E1.mov </link>
	<guid>http://www.vemcomeded.com/mrsa/LM1E1.mov </guid>
	<itunes:subtitle>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why MRSA is such a problematic pathogen.</itunes:subtitle>
	<itunes:summary>In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why MRSA is such a problematic pathogen. </itunes:summary>
	<enclosure url='http://www.vemcomeded.com/mrsa/LM1E1.mov'  length='7193368' type='video/mpeg'></enclosure>
	<itunes:keywords>mrsa, pathogen</itunes:keywords>
</item>
</channel>
</rss>
